Furthermore, we found that levels of CCL5 and VEGF-C in clinical specimens from patients with chondrosarcoma were correlated with tumor stage, implying that CCL5 may be a potential prognostic indicator for disease progression of human chondrosarcoma. The gene discussed is VEGFC; the disease is chondrosarcoma.